Wave Life Sciences (WVE) Non-Current Deffered Revenue: 2016-2025
Historic Non-Current Deffered Revenue for Wave Life Sciences (WVE) over the last 10 years, with Sep 2025 value amounting to $11.7 million.
- Wave Life Sciences' Non-Current Deffered Revenue fell 36.83% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.7 million, marking a year-over-year decrease of 36.83%. This contributed to the annual value of $6.1 million for FY2024, which is 60.91% down from last year.
- Wave Life Sciences' Non-Current Deffered Revenue amounted to $11.7 million in Q3 2025, which was up 176.02% from $4.2 million recorded in Q2 2025.
- Wave Life Sciences' Non-Current Deffered Revenue's 5-year high stood at $130.8 million during Q1 2023, with a 5-year trough of $4.2 million in Q2 2025.
- For the 3-year period, Wave Life Sciences' Non-Current Deffered Revenue averaged around $38.6 million, with its median value being $12.5 million (2024).
- As far as peak fluctuations go, Wave Life Sciences' Non-Current Deffered Revenue skyrocketed by 91.17% in 2021, and later tumbled by 90.83% in 2024.
- Quarterly analysis of 5 years shows Wave Life Sciences' Non-Current Deffered Revenue stood at $77.5 million in 2021, then climbed by 2.96% to $79.8 million in 2022, then crashed by 80.44% to $15.6 million in 2023, then tumbled by 60.91% to $6.1 million in 2024, then tumbled by 36.83% to $11.7 million in 2025.
- Its last three reported values are $11.7 million in Q3 2025, $4.2 million for Q2 2025, and $5.6 million during Q1 2025.